Caricamento...
Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey
Icatibant is used to treat acute hereditary angioedema with C1 inhibitor deficiency types I/II (C1‐INH‐HAE types I/II) and has shown promise in angioedema due to acquired C1 inhibitor deficiency (C1‐INH‐AAE). Data from the Icatibant Outcome Survey (IOS) were analysed to evaluate the effectiveness of...
Salvato in:
| Pubblicato in: | Clin Exp Immunol |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5343339/ https://ncbi.nlm.nih.gov/pubmed/27936514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12910 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|